|
Company News, New Products, Meetings where Cypex is Exhibiting
Company
News
27th
May 2009
Green enzymes! The WES 18/80 turbine is now operational, providing
electricity for the manufacture of Bactosomes. The turbine
will
provide much more power than is used by Cypex making the company a net
exporter of green energy.
27th
February 2009
Cypex demonstrates its commitment to support the advancement of
understanding xenobiotic metabolism by supporting the International
Society for the Study of Xenobiotics (ISSX)
at the highest, Major Donor, level for the second year running.
9th
February 2009
Cypex awarded a joint grant with Prof Andrew Munro, University of
Manchester for a CASE studentship entitled Evolution of efficient P450
biocatalysts for human drug metabolite generation.
20th
August 2008
Cypex is granted planning permission for the erection of an 80 kW wind
turbine. The turbine should provide up to twice the power consumed by
Cypex.
17th
June 2007
Cypex appoints Krishgen Biosystems as a distributor for the Indian market.
2nd
November 2006
Cypex appoints Precision Technologies as a distributor for Singapore, Malaysia, Indonesia and Thailand.
17th
April 2006
Cypex starts operating from new premises in Dundee Medipark.
10th
October 2005
Building work starts on Cypex's new headquarters and laboratory in
Dundee Medipark.
10th
January 2005
Cypex announces plans to build new headquarters and laboratory in
prestigious Medipark in Dundee. Planning permission has been granted
for a building that is three times the size of Cypex's current premises.
10th
December 2004
Cypex appoints AiBST as a distributor for the African
market.
1st
July 2004
Cypex
appoints
Jingmei Biotech Co. Ltd. as a distributor for its products in China and MGP Co. Ltd as a
distributor in the Czech Republic.
6th
October 2003
Cypex
and BioDynamics Research Ltd, Rushden, UK sign joint manufacturing /
distribution agreement. Cypex will distribute fine chemicals and drug
metabolites manufactured by BioDynamics Research Ltd as Cypex branded
products for drug metabolism studies.
1st
June 2003
Cypex appoints M/S LabPro India as a distributor for the Indian market.
18th
October 2002
Cypex acquires a non-exclusive licence from Brookhaven Science
Associates LLC for commercial use of their T7 RNA polymerase technology.
23rd
September 2002
Cypex appoints Nosan Corporation as a distributor for the Japanese market.
21st
March 2002
PPD Discovery (Wilmington, N.C.) announces licence agreement with
Cypex, giving Cypex a worldwide, non-exclusive licence to use PPD
Discovery's proprietary Pharmazyme™ technology. PPD Discovery
press
release
22nd
January 2002
Cypex appoints XenoTech as a distributor for the North American market.
6th
December 2001
Cypex is upgraded to ISO9001:2000 Quality Standard.
1st
October 2001
Cypex is appointed European distributor for Nosan Corporation's range
of anti-human cytochrome P450 antibodies.
New
products
16th
February 2010
CYP3A5BR
Bactosomes and CYP3A5BR EasyCYP Bactosomes
(co-expressed recombinant human CYP3A5
and human NADPH-cytochrome P450 reductase)
released for sale.
10th
February 2010
CYP2C8LR
Bactosomes (co-expressed recombinant human CYP2C8
and human NADPH-cytochrome P450 reductase)
released for sale.
21st
January 2010
CYP1A1LR
EasyCYP Bactosomes and CYP2C8LR EasyCYP Bactosomes
released for sale.
6th
January 2010
CYP3A5R
Bactosomes and CYP3A5R EasyCYP Bactosomes
(co-expressed recombinant human CYP3A5
and human NADPH-cytochrome P450 reductase)
released for sale.
30th
November 2009
Human SULT1C4
released for sale.
30th
September 2009
CYP3A5BLR EasyCYP Bactosomes (co-expressed recombinant human CYP3A5
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
21st
September 2009
CYP3A5BLR Bactosomes (co-expressed recombinant human CYP3A5
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
2nd
September 2009
Recombinant human aldehyde dehydrogenase ALDH1A1 released for sale.
19th
June 2009
Human SULT1C2
released for sale.
21st
April 2009
Human SULT1E1
released for sale.
17th
April 2009
Recombinant human carboxylesterase
2
released for sale.
16th
April 2009
CYP2C9*3BR
Bactosomes and CYP2C9*3BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2C9.3
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
8th
April 2009
CYP4A11BR
Bactosomes and CYP4A11BR EasyCYP Bactosomes
(co-expressed recombinant human CYP4A11
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
26th
March 2009
Human SULT2A1
released for sale.
17th
March 2009
Human SULT1A2
released for sale.
27th
February 2009
Human SULT1A1*2
released for sale.
28th
January 2009
Dog
CYP panel further extended with the release of dog CYP1A2LR
Bactosomes for
sale.
2nd
December 2008
CYP4F2BLR
EasyCYP Bactosomes (co-expressed recombinant human CYP4F2
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
27th
November 2008
Recombinant human carboxylesterase
1
released for sale.
29th
October 2008
CYP2C9*2BR
Bactosomes and CYP2C9*2BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2C9.2
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
28th
October 2008
CYP2B6BR
Bactosomes and CYP2B6BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2B6
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
21st
October 2008
New range of Bactosomes released, consisting of
seven dog CYPs,
each
co-expressed with dog NADPH-cytochrome P450 reductase.
3rd
October 2008
CYP4F2BLR
Bactosomes (co-expressed recombinant human CYP4F2
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
5th
August 2008
CYP2A13LR EasyCYP Bactosomes (co-expressed recombinant human CYP2A13
and human NADPH-cytochrome P450 reductase) released for sale.
8th
May 2008
CYP2C9*2R EasyCYP Bactosomes (co-expressed recombinant human CYP2C9.2
and human NADPH-cytochrome P450 reductase) released for sale.
23rd
April 2008
CYP2C9*3R EasyCYP Bactosomes (co-expressed recombinant human CYP2C9.3
and human NADPH-cytochrome P450 reductase) released for sale.
16th
April 2008
Recombinant human aldehyde
oxidase
released for sale.
24th
March 2008
CYP2C9*3R
Bactosomes (co-expressed recombinant human CYP2C9.3
and human NADPH-cytochrome P450 reductase) released for sale.
16th
January 2008
CYP2E1BR
Bactosomes and CYP2E1BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2E1
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
18th
December 2007
CYP2C9BHR
Bactosomes, CYP2C9BHR
EasyCYP Bactosomes, CYP2C9BR
Bactosomes and CYP2C9BR EasyCYP Bactosomes
(co-expressed recombinant human CYP2C9
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
5th December
2007
The CYP2C8 metabolite desethylamodiaquine
is
released
for sale.
12th
November 2007
The CYP2C8 substrate amodiaquine
is
released
for sale.
13th
September 2007
CYP3A4BLR
Bactosomes and CYP3A4BLR EasyCYP Bactosomes
(co-expressed recombinant human CYP3A4
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
7th
September 2007
CYP3A4BR
Bactosomes and CYP3A4BR EasyCYP Bactosomes
(co-expressed recombinant human CYP3A4
and human NADPH-cytochrome P450 reductase supplemented with human
cytochrome b5)
released for sale.
1st
August 2007
The CYP3A4 and CYP2J2 substrate terfenadine is
released
for sale.
18th
July 2007
The specific CYP2C19 inhibitor (-)-N-3-benzylphenobarbital is
released
for sale.
20th
February 2007
EasyCYP
range further extended with the release of CYP4A11LR EasyCYP Bactosomes for
sale.
4th
October 2006
EasyCYP
range further extended with the release of CYP1B1LR, CYP2C18LR,
CYP2D6*2R,
CYP2D6*10R
and CYP2J2LR
EasyCYP Bactosomes for sale.
18th
August 2006
CYP2J2LR Bactosomes (co-expressed recombinant human CYP2J2
and human NADPH-cytochrome P450 reductase) released for sale.
4th
August 2006
CYP2A13R Bactosomes (co-expressed recombinant human CYP2A13
and human NADPH-cytochrome P450 reductase) released for sale.
3rd
August 2006
EasyCYP
range further extended with the release of CYP1A1R, CYP3A5LR and CYP4A11R
EasyCYP Bactosomes for sale.
10th
July 2006
EasyCYP
range further extended with the release of CYP1A2LR, CYP2C9R, CYP2C19LR,
CYP2D6LR
and CYP3A4LR
EasyCYP Bactosomes for sale.
8th
June 2006
Larger pack size (5 mg) of 6alpha-hydroxypaclitaxel released
for sale.
2nd
June 2006
CYP2A13LR Bactosomes (co-expressed recombinant human CYP2A13
and human NADPH-cytochrome P450 reductase) released for sale.
30th
May 2006
Diclofenac
released for sale.
23rd
May 2006
EasyCYP
range extended with the release of CYP2A6R, CYP2B6R and CYP2E1R
EasyCYP Bactosomes for sale.
6th
April 2006
CYP2C9*2R Bactosomes (co-expressed recombinant human CYP2C9.2
and human NADPH-cytochrome P450 reductase) released for sale.
28th
March 2006
Ketoconazole
released for sale.
17th
March 2006
Paclitaxel
released for sale.
5th
December 2005
Tienilic acid
released for sale.
21st
October 2005
CYP2D6*39R Bactosomes (co-expressed recombinant human CYP2D6.39
and human NADPH-cytochrome P450 reductase) released for sale.
18th
October 2005
Human SULT1B1
released for sale.
3rd
October 2005
CYP2D6*10R Bactosomes (co-expressed recombinant human CYP2D6.10
and human NADPH-cytochrome P450 reductase) released for sale.
16th
August 2005
3-O-methylfluorescein
released for sale.
21st
June 2005
Omeprazole
released for sale.
19th
May 2005
EasyCYP
range extended with the release of CYP2C8R EasyCYP Bactosomes for sale.
15th
April 2005
First
five CYPs in the new convenient EasyCYP format released for sale.
Visit
our stand at the following meetings:
15th
Annual Society for Biomolecular Sciences (SBS) Meeting
Lille, France
April 26 - 30 2009
16th
North American ISSX Meeting
Baltimore, MD, USA
October 18 - 22 2009
Contact
Cypex for more information.
|
